Quinoline derivatives as phosphodiesterase inhibitors

Quinoline derivatives as phosphodiesterase inhibitors

There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BALDWIN IAN ROBERT,BARKER MICHAEL DAVID,DEAN ANTHONY WILLIAM,ELDRED COLIN DAVID,EVANS BRIAN,GOUGH SHARON LISA,GUNTRIP STEPHEN BARRY,HAMBLIN JULIE NICOLE,HOLMAN STUART,JONES PAUL,LINDVALL MIKA KRISTIAN, JANE,REDGRAVE ALISON JUDITH,ROBINSON JOHN EDWARD,WOODROW MICHAEL
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There are provided according to the invention novel compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20 and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.